Skip Navigation
Print This Page
Share this page: More

Clinical Trials

Current Studies

The Pituitary Center is actively recruiting participants for the following studies:

A Phase 3, Multicenter Study Designed to Evaluate the Efficacy and Safety of a Long Acting Hgh Product (Mod-4023) in Adult Subjects with Growth Hormone Deficiency

Condition: Adult Growth Hormone Deficiency
Interventions: Drug: MOD-4023; Other: Placebo
Principle Investigator:  Roberto Salvatori, MD

Treatment for Endogenous Cushing's Syndrome

Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003 (Levoketoconazole)
Principle Investigator:  Roberto Salvatori, MD

Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease

Condition: Cushing's Disease
Intervention: Drug: LCI699
Principle Investigator:  Roberto Salvatori, MD

Learn more

To learn more about this clinical trial please visit:
If interested, contact the Study Coordinator at 410-502-0033 or Roberto Salvatori, MD, Principal Investigator at 410-955-3921.


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.